Simonian Nancy A
- SEC CIK
- 0001359574
No open-market purchases or sales filed in the past year.
Current role at each company
- GENB Generate Biomedicines, Inc.Directoras of Mar 2, 2026
- SYRS Syros Pharmaceuticals, Inc.Directoras of Dec 4, 2024
- SGEN Seagen Inc.Directoras of Dec 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Simonian Nancy A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SYRS Syros Pharmaceuticals, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2024 (view filing)5:00 PM ET | Dec 2 | 2 days | Simonian Nancy ADirector | SSale | −37.1K | $0.2702 | −$10.0K | −90.3%4.00K after | |
| Nov 27, 2024 (view filing)5:00 PM ET | Nov 25 | 2 days | Simonian Nancy ADirector | SSale | −134.7K | $0.2653 | −$35.7K | −76.6%41.1K after |